Solventum Lifts 2026 Earnings Forecast Following Third-Quarter Results
Solventum raised its full-year earnings guidance after reporting third-quarter adjusted profit that topped expectations, even as the unwind of prior system orders lowered quarterly sales.
Solventum Corporation raised its full-year 2026 financial guidance after reporting third-quarter adjusted earnings that surpassed Wall Street projections. Management increased its adjusted earnings per share outlook to a range between $7.20 and $7.30 and stated it anticipates full-year organic revenue expansion near the high end of its prior 2.5% to 3.0% forecast.
For the third quarter, the healthcare company reported revenue of $1.95 billion, down 7% from a year earlier, and adjusted earnings per share of $1.45. According to Zacks Consensus Estimates, analysts had expected earnings of $1.35 per share on sales of $1.97 billion. On a GAAP basis, the business logged a net loss of $12 million, or 7 cents per share, contrasted with earnings of $7.22 per share in the prior-year quarter.
Reported quarterly performance was dampened by an expected $125 million reversal of advance purchases that clients placed in the second quarter prior to enterprise resource planning transitions. Chief Financial Officer Wayde McMillan noted this shift subtracted approximately 6.3 percentage points from organic sales, which fell 2.8% overall. Accounting for the timing of those system orders alongside product line reductions, underlying organic revenue rose around 4%.
Company leadership highlighted operational separation milestones, noting that the business finished its largest enterprise resource planning system transition and has now resolved over 90% of its split from 3M. A revised supply contract with 3M eliminates an expected 1-percentage-point gross margin obstacle starting in 2027. Meanwhile, the recent acquisition of Acera provided $35 million in revenue, advancing 35% during the period.
Following the financial release, Solventum shares gained 4.6% to reach $91.19 in afternoon trading, bringing year-to-date appreciation to 15.4%. FinancialContent reported the price hovered close to its 52-week peak of $92.44 established in September 2026.